Christoph J Griessenauer1, Mohamed Salem2, Philipp Hendrix3, Paul M Foreman4, Christopher S Ogilvy2, Ajith J Thomas2. 1. Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: christoph.griessenauer@gmail.com. 2. Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. 3. Department of Neurosurgery, Saarland University Hospital, Homburg/Saar, Germany. 4. Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Abstract
BACKGROUND: Spinal tumors are referred for preoperative embolization to minimize intraoperative blood loss and facilitate surgical resection. OBJECTIVE: To perform a systematic review and meta-analysis and provide comprehensive data on embolization technique, efficacy, and complications. METHODS: A systematic review of PubMed articles was performed with the following inclusion criteria: original studies, studies of ≥ 10 patients (except Onyx because of the scarcity of available data), embolization through vascular access, and reporting of the embolic agent used. In addition, the manuscript needed to contain at least 1 of the following variables: demographics, tumor type, location, vascularity, degree of devascularization, complications, time to operation, type of operation, estimated blood loss (EBL), and use of blood transfusion. RESULTS: Thirty-seven studies with a total of 1305 patients met inclusion criteria. Renal cell carcinoma was the most commonly embolized tumor, comprising 47.4% (95% confidence interval [95% CI] 39.4-55.4) of all tumor embolizations. The rate of complete devascularization for all tumor types was 68.3% (95% CI 60.0-76.6). There was a significant decrease in operative EBL in more recently published studies compared with earlier studies; however, the rate of complete embolization remained stable. Polyvinyl alcohol and Onyx were associated with similar EBL and rates of complete embolization. The overall complication rate was 3.1% (95% CI 1.2-4.9). CONCLUSIONS: The rapid evolution of neurointervention and spinal tumor embolization has made scientific inquiry and definitive conclusion on the safety and efficacy of the practice difficult. The data supporting the procedure are fragmented and largely based on a multitude of retrospective studies that use varying techniques. Review of the available literature support embolization of spinal tumors as a safe and efficacious treatment adjunct before surgery.
BACKGROUND:Spinal tumors are referred for preoperative embolization to minimize intraoperative blood loss and facilitate surgical resection. OBJECTIVE: To perform a systematic review and meta-analysis and provide comprehensive data on embolization technique, efficacy, and complications. METHODS: A systematic review of PubMed articles was performed with the following inclusion criteria: original studies, studies of ≥ 10 patients (except Onyx because of the scarcity of available data), embolization through vascular access, and reporting of the embolic agent used. In addition, the manuscript needed to contain at least 1 of the following variables: demographics, tumor type, location, vascularity, degree of devascularization, complications, time to operation, type of operation, estimated blood loss (EBL), and use of blood transfusion. RESULTS: Thirty-seven studies with a total of 1305 patients met inclusion criteria. Renal cell carcinoma was the most commonly embolized tumor, comprising 47.4% (95% confidence interval [95% CI] 39.4-55.4) of all tumor embolizations. The rate of complete devascularization for all tumor types was 68.3% (95% CI 60.0-76.6). There was a significant decrease in operative EBL in more recently published studies compared with earlier studies; however, the rate of complete embolization remained stable. Polyvinyl alcohol and Onyx were associated with similar EBL and rates of complete embolization. The overall complication rate was 3.1% (95% CI 1.2-4.9). CONCLUSIONS: The rapid evolution of neurointervention and spinal tumor embolization has made scientific inquiry and definitive conclusion on the safety and efficacy of the practice difficult. The data supporting the procedure are fragmented and largely based on a multitude of retrospective studies that use varying techniques. Review of the available literature support embolization of spinal tumors as a safe and efficacious treatment adjunct before surgery.
Authors: Anna Voelker; Georg Osterhoff; Stefanie Einhorn; Sebastian Ebel; Christoph-Eckhard Heyde; Philipp Pieroh Journal: World J Surg Oncol Date: 2022-06-16 Impact factor: 3.253
Authors: Waseem Wahood; Alex Yohan Alexander; Yagiz Ugur Yolcu; Waleed Brinjikji; David F Kallmes; Giuseppe Lanzino; Mohamad Bydon Journal: Neurointervention Date: 2021-02-04
Authors: Michael Travis Caton; Eric Robert Smith; Amanda Baker; Christopher Foley Dowd; Randall T Higashida Journal: Neurointervention Date: 2022-03-28